If approved, it would represent a significant step above what tirzepatide currently offers particularly for patients with very high starting BMIs or those who have plateaued at maximum tirzepatide doses
, AlMassarani, S
Daniel Drucker, one of the pioneers in GLP-1 research, put it perfectly: Theres something about GLP-1 that mitigates a lot of chronic diseases that people have, and we really need to understand better how that works. Studies appearing in multiple journals have demonstrated these drugs possess systemic anti-inflammatory and cardioprotective effects
In addition, established research has shown the suppression in 7nAChR resulting in massive brain oxidative stress with high levels of oxidative markers, including malondialdehyde (MDA) and nitric oxide (NO) with decreased antioxidant enzyme activity, including glutathione peroxidase (GPx) and glutathione (GSH), and all these findings result in developing ASD [36, 62, 70, 71]
For instance, selenium and tellurium nano-compounds have recently attracted the attention of many researchers due to their excellent ROS sensitivity
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
